Drug or treatment

Zimberelimab clinical trials

• 7Clinical trials
• 7Countries

Newest trials

All recruiting trials (7)

• Futibatinib and immunotherapy with chemo as first-line treatment for advanced biliary tract cancer

  A first-line treatment test combines Futibatinib with Zimberelimab and Gemcitabine/Cisplatin to see if it improves survival in people with unresectable or advanced biliary tract cancer.

  Recruiting at 4 sites Phase 3 Taiho Pharmaceutical Co., Ltd. · Brisbane and 20 other locations · NCT07710885

• Becotatug Vedotin plus Zimberelimab in recurrent/metastatic cervical, vulvar, and vaginal cancers

  This study tests a targeted cancer drug linked to a toxin with a PD-1 blocker in women with recurrent or metastatic cervical, vulvar, or vaginal cancers who have already tried standard therapies.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07424664

• Treatment for lung cancer patients who had surgery but are not disease-free

  This study is testing two new immunotherapy treatments for lung cancer patients who have had surgery but still have some disease to see if they can help them stay cancer-free longer.

  Recruiting at 31 sites Phase 3 Fundación GECP · Alicante, Alicante and 31 other locations · NCT06431633

• Combining Sacituzumab Govitecan and Zimberelimab with Stereotactic Radiation for Metastatic Triple Negative Breast Cancer with Brain Metastases

  This study is testing if combining two treatments, Sacituzumab Govitecan and Zimberelimab, with targeted radiation can help adults with metastatic triple negative breast cancer that has spread to the brain feel better compared to just using Sacituzumab Govitecan alone.

  Recruiting Phase 1/2 H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida · NCT06238921

• Treatment for recurrent or metastatic cervical cancer using RC48-ADC and Zimberelimab

  This study is testing a new combination treatment of RC48-ADC and Zimberelimab for patients with recurrent or metastatic cervical cancer that has HER2 expression and hasn't responded to previous platinum-based therapies.

  Recruiting Phase 2 RemeGen Co., Ltd. · Bengbu, Anhui and 11 other locations · NCT06155396

• Combining Zimberelimab with Paclitaxel and Cisplatin for Cervical Cancer Treatment

  This study is testing if a new treatment combining Zimberelimab with two chemotherapy drugs can help women with advanced cervical cancer shrink their tumors before surgery.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT06055738

• Combining zimberelimab and quemliclustat with chemotherapy for advanced pancreatic cancer

  This study is testing if a new combination of zimberelimab and quemliclustat with chemotherapy can help people with advanced pancreatic cancer live longer and have better treatment outcomes.

  Recruiting Phase 1/2 Jonsson Comprehensive Cancer Center · Los Angeles, California · NCT05688215

Quick answers

How many clinical trials of Zimberelimab are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in China (3 trials), United States (2 trials), Spain (1 trial), Australia (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →